These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32196626)

  • 21. The Microbiome: What Will the Future Hold?
    Monsour HP; Quigley EM
    Semin Liver Dis; 2016 Sep; 36(4):354-359. PubMed ID: 27997976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.
    Li Y; Tang R; Leung PSC; Gershwin ME; Ma X
    Autoimmun Rev; 2017 Sep; 16(9):885-896. PubMed ID: 28698093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of gut microbiota in liver disease.
    Albhaisi SAM; Bajaj JS; Sanyal AJ
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G84-G98. PubMed ID: 31657225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The human gut microbiota: Interactions with the host and dysfunctions].
    Lepage P
    Rev Mal Respir; 2017 Dec; 34(10):1085-1090. PubMed ID: 28506730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gut microbiota-an important contributor to liver diseases].
    Wang F; Cui Q; Zeng Y; Chen P
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Apr; 40(4):595-600. PubMed ID: 32895142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbiome and liver diseases.
    Tilg H; Cani PD; Mayer EA
    Gut; 2016 Dec; 65(12):2035-2044. PubMed ID: 27802157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of gut microbiota in chronic liver diseases, and treatment possibilities].
    Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G
    Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?
    Brandl K; Schnabl B
    Expert Rev Gastroenterol Hepatol; 2015; 9(8):1069-76. PubMed ID: 26088524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Introduction.
    Chen P
    Adv Exp Med Biol; 2020; 1238():1-10. PubMed ID: 32323176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiota, immunity and the liver.
    Vaikunthanathan T; Safinia N; Lombardi G; Lechler RI
    Immunol Lett; 2016 Mar; 171():36-49. PubMed ID: 26835593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The fingerprint of the human gastrointestinal tract microbiota: a hypothesis of molecular mapping.
    Tomasello G; Mazzola M; Jurjus A; Cappello F; Carini F; Damiani P; Gerges Geagea A; Zeenny MN; Leone A
    J Biol Regul Homeost Agents; 2017; 31(1):245-249. PubMed ID: 28337900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases.
    Binda C; Gibiino G; Coluccio C; Sbrancia M; Dajti E; Sinagra E; Capurso G; Sambri V; Cucchetti A; Ercolani G; Fabbri C
    Microorganisms; 2022 Jan; 10(2):. PubMed ID: 35208765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
    Chen B; Sun L; Zhang X
    J Autoimmun; 2017 Sep; 83():31-42. PubMed ID: 28342734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biliary microbiome in pancreatic cancer: alterations with neoadjuvant therapy.
    Goel N; Nadler A; Reddy S; Hoffman JP; Pitt HA
    HPB (Oxford); 2019 Dec; 21(12):1753-1760. PubMed ID: 31101398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging concepts in biliary repair and fibrosis.
    Fabris L; Spirli C; Cadamuro M; Fiorotto R; Strazzabosco M
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G102-G116. PubMed ID: 28526690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease.
    Chen YY; Chen DQ; Chen L; Liu JR; Vaziri ND; Guo Y; Zhao YY
    J Transl Med; 2019 Jan; 17(1):5. PubMed ID: 30602367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The gut microbiome alterations in allergic and inflammatory skin diseases - an update.
    Polkowska-Pruszyńska B; Gerkowicz A; Krasowska D
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):455-464. PubMed ID: 31520544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of microorganisms in biliary tract disease.
    Ljungh A; Wadström T
    Curr Gastroenterol Rep; 2002 Apr; 4(2):167-71. PubMed ID: 11900683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defense system in the biliary tract against bacterial infection.
    Sung JY; Costerton JW; Shaffer EA
    Dig Dis Sci; 1992 May; 37(5):689-96. PubMed ID: 1563308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut microbiota and Hashimoto's thyroiditis.
    Virili C; Fallahi P; Antonelli A; Benvenga S; Centanni M
    Rev Endocr Metab Disord; 2018 Dec; 19(4):293-300. PubMed ID: 30294759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.